Bristol Myers trades higher after the FDA approves an oral medication for schizophrenia in adults, fiscal fourth-quarter ...

U.S. stock indexes are drifting around their records as hopes hold that the economy can pull off the feat of getting ...

Developed by Karuna Therapeutics, which was subsequently acquired by Bristol Myers Squibb, the drug works in an entirely ...

The US Food and Drug Administration has approved Cobenfy, which is owned by pharmaceutical firm Bristol Myers Squibb.

The first new kind of treatment for schizophrenia patients in decades is arriving. The U.S. Food and Drug Administration ...

U.S. equities were mixed at midday as the Federal Reserve's favored measure of inflation was lower than anticipated.

Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of all purchasers of stock of Metagenomi, Inc. pursuant and/or traceable to the Company's ...

Bristol Myers Squibb (BMY) is up more than +2% after gaining FDA approval for its Cobenfy drug to treat patients with schizophrenia. Amgen (AMGN) is up more than +1% after Cantor Fitzgerald initiated ...

The blue-chip Dow rose on Friday to hit an intraday record and small-cap stocks outperformed after a benign inflation report ...

ABC News' Linsey Davis speaks with White House National Security spokesman John Kirby on the latest in the cease-fire negotiations between Lebanon and Israel as tensions escalate in the region.

Bristol Myers Squibb received U.S. Food and Drug Administration (FDA) approval on Thursday for its groundbreaking ...

A leading rights group says Rwanda’s army and a militia it backs shelled camps for displaced people in eastern Congo. Human ...